| Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male Volunteers (NCT01541488) | Boehringer Ingelheim | 2012-02-01 |
| A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis (NCT01543191) | Pulmatrix Inc. | 2012-02-01 |
| Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults (NCT01540474) | U.S. Army Medical Research and Development Command | 2012-02-01 |
| Use of Interactive Gaming for Enhanced Function After Spinal Cord Injury (NCT01537978) | VA Palo Alto Health Care System | 2012-02-01 |
| Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance (NCT01690247) | Beijing 302 Hospital | 2012-02-01 |
| Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging (NCT01522378) | Mayo Clinic | 2012-02-01 |
| Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults (NCT01634178) | Amgen | 2012-02-01 |
| First in Man Trial of BI 113608 (NCT01540825) | Boehringer Ingelheim | 2012-02-01 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma (NCT01465347) | Diffusion Pharmaceuticals Inc | 2012-02-01 |
| Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients (NCT01558934) | USWM, LLC (dba US WorldMeds) | 2012-02-01 |
| Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer (NCT01174199) | Roswell Park Cancer Institute | 2012-02-01 |
| Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects (NCT01537640) | Sanofi | 2012-02-01 |
| Mesenchymal Stem Cells After Renal or Liver Transplantation (NCT01429038) | University of Liege | 2012-02-01 |
| Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin (NCT01525823) | Bristol-Myers Squibb | 2012-02-01 |
| Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition (NCT01567501) | IPCA Laboratories Ltd. | 2012-02-01 |
| Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 (NCT01520896) | AstraZeneca | 2012-02-01 |
| A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers (NCT01548703) | BrainCells Inc. | 2012-02-01 |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (NCT01231399) | City of Hope Medical Center | 2012-02-01 |
| Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo (NCT01900171) | Quantum Genomics SA | 2012-02-01 |
| Effects of Curcumin on Vascular Reactivity (NCT01543386) | University Hospital, Clermont-Ferrand | 2012-02-01 |
| A Study of LY2886721 in Healthy Participants (NCT01534273) | Eli Lilly and Company | 2012-02-01 |
| Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion (NCT01557907) | Becton, Dickinson and Company | 2012-02-01 |
| Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors (NCT01773018) | Hutchison Medipharma Limited | 2012-02-01 |
| Exploratory Study of Propofol and Fentanyl Pharmacodynamics (NCT01550770) | Ethicon Endo-Surgery | 2012-02-01 |
| Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer (NCT01505153) | Gradalis, Inc. | 2012-02-01 |
| A Study of BBI503 in Adult Patients With Advanced Solid Tumors (NCT01781455) | Sumitomo Pharma America, Inc. | 2012-02-01 |
| Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma (NCT01498835) | Heidelberg University | 2012-02-01 |
| Improving Fecal Occult Blood Test Completion Rates Among Veterans (NCT01516489) | Corporal Michael J. Crescenz VA Medical Center | 2012-02-01 |
| Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis (NCT01534884) | Celltrion | 2012-02-01 |
| Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases (NCT01447056) | Baylor College of Medicine | 2012-02-01 |
| Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule (NCT01555398) | Hanmi Pharmaceutical Company Limited | 2012-02-01 |
| A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101 (NCT01668199) | Norgine | 2012-02-01 |
| A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately (NCT01534247) | Pfizer | 2012-02-01 |
| Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib (NCT01539655) | Sanofi | 2012-02-01 |
| Influenza A 2009 H1N1 Challenge Study in Healthy Adults (NCT01646138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer (NCT01542879) | Heike E Daldrup-Link | 2012-02-01 |
| Effects of Acute Estrogen Therapy on Bone Formation (NCT02349113) | Mayo Clinic | 2012-02-01 |
| Endothelial Dysfunction and Oxidative Stress in Children With Sleep Disordered Breathing. (NCT02247167) | University of Roma La Sapienza | 2012-02-01 |
| Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine (NCT01540500) | Vanda Pharmaceuticals | 2012-02-01 |
| Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration (NCT01420042) | Neuren Pharmaceuticals Limited | 2012-02-01 |
| Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence (NCT01467999) | New York State Psychiatric Institute | 2012-02-01 |
| A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants (NCT01515358) | Eli Lilly and Company | 2012-02-01 |
| Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function (NCT01526746) | Vanda Pharmaceuticals | 2012-02-01 |
| Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) (NCT01352858) | Newcastle University | 2012-02-01 |
| Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV (NCT01535885) | Medical College of Wisconsin | 2012-02-01 |
| The Effects of Dopamine on Reward Processing (NCT01253421) | Mclean Hospital | 2012-02-01 |
| A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics (NCT01607762) | Janssen Research & Development, LLC | 2012-02-01 |
| A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers (NCT01519336) | Hoffmann-La Roche | 2012-02-01 |
| Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer (NCT01611506) | Dr Anna Dorothea Wagner | 2012-02-01 |
| Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition (NCT01557439) | IPCA Laboratories Ltd. | 2012-02-01 |
| Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma (NCT01522872) | Threshold Pharmaceuticals | 2012-02-01 |
| Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin (NCT01540487) | Boehringer Ingelheim | 2012-02-01 |
| Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine (NCT01545349) | Patricia L. Hibberd | 2012-02-01 |
| Nurigra Chewable Tablet in Healthy Adult Male Volunteers (NCT01651858) | Daewoong Pharmaceutical Co. LTD. | 2012-02-01 |
| Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study (NCT01554540) | University Hospital, Grenoble | 2012-02-01 |
| Effect of Mindfulness Training on Sleep and Inflammation Among Older Adults With Sleep Problems (NCT01534338) | University of California, Los Angeles | 2012-02-01 |
| The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers (NCT01530464) | Thies Schroeder | 2012-02-01 |
| Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg (NCT01494727) | HK inno.N Corporation | 2012-02-01 |
| A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge (NCT01539473) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-02-01 |
| Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer (NCT01535157) | South Plains Oncology Consortium | 2012-02-01 |
| Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients (NCT01637493) | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | 2012-02-01 |
| IL-2 for Multi Drug Resistant Nephrotic Syndrome (NCT02455908) | Istituto Giannina Gaslini | 2012-02-01 |
| Multiple Ascending Oral Dose Phase I Study With Px-102 (NCT01998672) | Phenex Pharmaceuticals AG | 2012-02-01 |
| The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence (NCT01535937) | New York State Psychiatric Institute | 2012-02-01 |
| Phase I/IIa Dose-escalation Clinical Study of VAC-3S (NCT01549119) | InnaVirVax | 2012-02-01 |
| AMG 595 First-in-Human in Recurrent Gliomas (NCT01475006) | Amgen | 2012-02-01 |
| Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer (NCT01490749) | Emory University | 2012-02-01 |
| Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers (NCT01529320) | Fundacion IMIM | 2012-02-01 |
| Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers (NCT01550458) | Cavion, Inc. | 2012-02-01 |
| Cognitive and Neural Effects of ARA290 (NCT02070783) | Leiden University Medical Center | 2012-02-01 |
| Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) (NCT01213979) | Pharmacosmos A/S | 2012-02-01 |
| Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. (NCT02165046) | Intech Biopharm Ltd. | 2012-02-01 |
| ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer (NCT01242605) | University College, London | 2012-02-01 |
| EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks (NCT01349140) | University of California, San Diego | 2012-02-01 |
| A Study of LY3025876 in Healthy Volunteers (NCT01528124) | Eli Lilly and Company | 2012-02-01 |
| Pharmacokinetics of Tenofovir, Emtricitabine, Maraviroc, and Raltegravir in Cervical, Vaginal, and Rectal Tissues and Secretions (NCT01330199) | University of North Carolina, Chapel Hill | 2012-02-01 |
| Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma (NCT01541332) | Oncotherapeutics | 2012-02-01 |
| Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers (NCT01841476) | Polyphor Ltd. | 2012-02-01 |
| Alcohol Inhibits Drug Metabolism by Carboxylesterases (NCT01708369) | University of Tennessee | 2012-02-01 |
| Pilot Study to Evaluate the Effect of ENI Patented Whole Grape Extract on Antioxidant Status (NCT01551706) | Ethical Naturals, Inc. | 2012-02-01 |
| Radical Lung Radiotherapy Plus Nelfinavir (NCT01447589) | Oxford University Hospitals NHS Trust | 2012-02-01 |
| Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration (NCT01908894) | Biodel | 2012-02-01 |
| A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01500798) | Biogen | 2012-01-31 |
| Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer (NCT01495247) | Novartis Pharmaceuticals | 2012-01-30 |
| A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056) (NCT01431534) | Merck Sharp & Dohme LLC | 2012-01-30 |
| A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013) (NCT01460719) | Merck Sharp & Dohme LLC | 2012-01-24 |
| A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies (NCT01224730) | AEterna Zentaris | 2012-01-24 |
| Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001) (NCT01475370) | Otsuka Pharmaceutical Co., Ltd. | 2012-01-24 |
| Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer (NCT01565928) | Pfizer | 2012-01-24 |
| Pazopanib and ARQ 197 for Advanced Solid Tumors (NCT01468922) | National Cancer Institute (NCI) | 2012-01-23 |
| Translocator Protein and Inflammation After Traumatic Brain Injury (NCT01547780) | National Institute of Mental Health (NIMH) | 2012-01-20 |
| Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067) (NCT01512667) | Merck Sharp & Dohme LLC | 2012-01-17 |
| Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects (NCT01496677) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-01-17 |
| MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC. (NCT01498952) | MedImmune LLC | 2012-01-17 |
| First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects (NCT01514500) | Novo Nordisk A/S | 2012-01-16 |
| A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol (NCT01540708) | GlaxoSmithKline | 2012-01-16 |
| An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed (NCT01583036) | GlaxoSmithKline | 2012-01-16 |
| Improving Blood Stem Cell Collection and Transplant Procedures (NCT01517035) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-01-13 |
| Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia (NCT01578109) | National Cancer Institute (NCI) | 2012-01-13 |
| Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. (NCT01597700) | GlaxoSmithKline | 2012-01-13 |